Can a Relationship-Focused program boost HIV prevention in african immigrants?

NCT ID NCT07565584

Not yet recruiting Knowledge-focused Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This pilot study looks at how migration experiences and social bonds influence HIV prevention decisions among first-generation African immigrants aged 18-50 in New York and Massachusetts. Researchers will work with the community to develop a relationship-tailored behavioral intervention and test if it is acceptable and feasible. Participants will take part in interviews, surveys, and group discussions, with no comparison group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Relationship-Centered HIV Prevention Intervention Component (behavioral intervention)
What this could lead to: If successful, this could lead to a culturally tailored HIV prevention program that improves testing and PrEP uptake among African immigrants.
What could go wrong: This is a small, early-stage pilot study with no comparison group, so results may not be generalizable. The intervention is still being developed and tested for feasibility.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coitus HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION HIV TESTING SEXUAL AND REPRODUCTIVE HEALTH

Contacts and locations

Locations

State University of New York at Buffalo

Buffalo, New York, 14214, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.